Cancer statistics for the US Hispanic/Latino population, 2021

Abstract

The Hispanic/Latino population is the second largest racial/ethnic group in the continental United States and Hawaii, accounting for 18% (60.6 million) of the total population. An additional 3 million Hispanic Americans live in Puerto Rico. Every 3 years, the American Cancer Society reports on cancer occurrence, risk factors, and screening for Hispanic individuals in the United States using the most recent population‐based data. An estimated 176,600 new cancer cases and 46,500 cancer deaths will occur among Hispanic individuals in the continental United States and Hawaii in 2021. Compared to non‐Hispanic Whites (NHWs), Hispanic men and women had 25%‐30% lower incidence (2014‐2018) and mortality (2015‐2019) rates for all cancers combined and lower rates for the most common cancers, although this gap is diminishing. For example, the colorectal cancer (CRC) incidence rate ratio for Hispanic compared with NHW individuals narrowed from 0.75 (95% CI, 0.73‐0.78) in 1995 to 0.91 (95% CI, 0.89‐0.93) in 2018, reflecting delayed declines in CRC rates among Hispanic individuals in part because of slower uptake of screening. In contrast, Hispanic individuals have higher rates of infection‐related cancers, including approximately two‐fold higher incidence of liver and stomach cancer. Cervical cancer incidence is 32% higher among Hispanic women in the continental US and Hawaii and 78% higher among women in Puerto Rico compared to NHW women, yet is largely preventable through screening. Less access to care may be similarly reflected in the low prevalence of localized‐stage breast cancer among Hispanic women, 59% versus 67% among NHW women. Evidence‐based strategies for decreasing the cancer burden among the Hispanic population include the use of culturally appropriate lay health advisors and patient navigators and targeted, community‐based intervention programs to facilitate access to screening and promote healthy behaviors. In addition, the impact of the COVID‐19 pandemic on cancer trends and disparities in the Hispanic population should be closely monitored.

Ultrasound-Assisted Natural Deep Eutectic Solvent Extraction and Bioactivities of Flavonoids in Ampelopsis grossedentata Leaves

“…Cancer is one of three major diseases that threaten human life and health. It has the highest mortality rate, besides heart disease and infectious diseases, and accounts for one-fourth of all deaths every year [ 37 ]. Anti-cancer drugs include synthetic drugs and natural plant extracts.…”

Identification of Long Noncoding RNAs Associated With the Clinicopathological Features of Papillary Thyroid Carcinoma Complicated With Hashimoto’s Thyroiditis

“…Papillary thyroid cancer (PTC) is the most common subtype of thyroid cancer, which is the fourth most common cancer in Hispanic women in the USA, and over 586,000 cases worldwide ( 1 , 2 ). Hashimoto’s thyroiditis (HT, also known as chronic lymphocytic thyroiditis, CLT) is the most common autoimmune thyroid disease, and its pathology is characterized by fibrosis, diffuse lymphocyte infiltration, and parenchymal atrophy.…”

LINC01137 involvement in pancreatic cancer stemness via the miR-7155-5p/KLF12/AKT axis

“…PDAC is the most common type of pancreatic malignant cancer (accounting for almost 85% of cases) (Vincent et al,2011), and it remains an urgent worldwide healthcare problem. In America, it is the fourth leading cause of cancer death regardless of sex, also ranking 7 th in China and 5 th in males and 4 th in females in the US Hispanic/Latino population, respectively (Chen et al,2016;Miller et al,2021;Siegel et al,2021). Surgery is the only way to prolong PDAC patient survival.…”